Intellia Therapeutics competitors

Intellia Therapeutics's competitors include CRISPR Therapeutics, Aevi Genomic Medicine, Ultragenyx Pharmaceutical and Illumina
Add company...
Intellia Therapeutics
Intellia is developing therapeutic products to help people with genetic diseases.
CRISPR Therapeutics
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Aevi Genomic Medicine
Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Illumina
Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.
Founding Date
Founding Date
2014
Founding Date
2013
Founding Date
2000
Founding Date
2010
Founding Date
1998
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Zug, CH HQ
Greater London, GB
Cambridge, US
Locations
Wayne, US HQ
San Francisco, US
Locations
Novato, US HQ
Locations
San Diego, US HQ
Scoresby, AU
São Paulo, BR
Victoria, CA
Shanghai, CN
Beijing, CN
Minato, JP
see more
Employees
Employees
10470% increase
Employees
93
Employees
24
Employees
376
Employees
6,20013% increase
Valuation ($)
Valuation ($)
1.2 b
Valuation ($)
2.1 b
Valuation ($)
75.4 m
Valuation ($)
4.3 b
Valuation ($)
52.6 b
Twitter followers
Twitter followers
2.2 k
Twitter followers
3.5 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
57 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$133k (FY, 2016)
Revenue (est.)
$2.4b (FY, 2017)
Net income
Net income
($10.6b) (FY, 2016)
Net income
($68.4m) (FY, 2017)
Net income
($34.7m) (FY, 2017)
Net income
($245.9m) (FY, 2016)
Net income
$428.1m (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 127m
Total funding raised
$ 7m
Total funding raised
$ 200.1m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

CRISPR Therapeutics
HQ
Zug, CH
Employees
93

CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.

View company
Aevi Genomic Medicine
HQ
Wayne, US
Employees
24

Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.

View company
Ultragenyx Pharmaceutical
HQ
Novato, US
Employees
376

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

View company
Illumina
HQ
San Diego, US
Employees
6,200↑ 13% increase

Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.

View company